MHP-RT 5mg + Cagrilintide 5mg |Blend (10mg Total) | Research Material

MHP-RT 5mg + Cagrilintide 5mg |Blend (10mg Total)
Research Material

MHP-RT 5mg + Cagrilintide 5mg |Blend (10mg Total)

Account access required Registered customers may sign in to access additional product information and purchasing functionality.
Login or Create Account

MHP-RT 5mg + Cagrilintide 5mg | Metabolic Research Blend 10mg | Mile High Peptides LLC

Research Areas of Interest

MHP-RT and Cagrilintide are investigated in laboratory and preclinical
research involving:

  • GLP-1, GIP, and glucagon receptor signaling
  • Amylin receptor signaling
  • Metabolic signaling pathways
  • Glucose and lipid metabolism research
  • Energy-balance and homeostatic mechanisms
  • Cellular responses to metabolic signaling
  • Interactions among GLP-1, GIP, glucagon, and amylin signaling pathways

These areas represent subjects of laboratory and preclinical investigation
and do not indicate safety, effectiveness, therapeutic benefit, or
suitability for human use.

Description

The MHP-RT 5mg + Cagrilintide 5mg Research Blend
combines equal quantities of MHP-RT and Cagrilintide in a single
10mg lyophilized research preparation.

MHP-RT is investigated in preclinical research involving
GLP-1, GIP, and glucagon receptor pathways and associated metabolic
signaling mechanisms.

Cagrilintide is investigated in research involving
amylin receptor pathways and associated metabolic and energy-regulation
signaling.

Combining the two compounds in a defined research preparation allows
investigators to examine interactions among GLP-1, GIP, glucagon,
and amylin-associated signaling pathways within appropriately designed
experimental models.

Blend Composition

  • MHP-RT: 5mg
  • Cagrilintide: 5mg
  • Total research material: 10mg
  • Ratio: 1:1

Product Details

  • Components: MHP-RT + Cagrilintide
  • MHP-RT quantity: 5mg
  • Cagrilintide quantity: 5mg
  • Total compound: 10mg
  • Format: Lyophilized powder
  • Blend format: Single blended research preparation
  • Intended use: Laboratory research only
  • Application: Analytical and in-vitro research

Research Information

MHP-RT is investigated in experimental models involving multiple
receptor-mediated metabolic signaling pathways, including GLP-1,
GIP, and glucagon receptor activity.

Cagrilintide is investigated in preclinical models involving
amylin-associated signaling and its relationship with metabolic
and energy-regulation pathways.

The combined preparation may be incorporated into appropriately
designed experimental models examining interactions between
incretin, glucagon, and amylin-associated signaling systems.

Research observations may vary depending on methodology, handling,
storage conditions, experimental environment, and study design.

Important Notice

  • For laboratory research and educational purposes only
  • Not for human consumption
  • Not for human or veterinary use
  • Not for medical, cosmetic, or therapeutic use
  • Not intended to diagnose, treat, cure, or prevent any disease
  • Research observations may vary based on methodology, handling, storage, environment, and experimental conditions
  • Material supplied is not a finished consumer product

Research Use Only

This material is supplied strictly for laboratory research and
analytical applications. It is not intended for human consumption
or for medical, cosmetic, veterinary, or therapeutic use.

Mile High Peptides LLC supplies this material strictly for analytical
and in-vitro laboratory research applications by qualified research
professionals.

Mile High Peptides LLC research materials are intended for laboratory, analytical, and educational research purposes only. They are not intended for human or veterinary use and are not represented as medical, therapeutic, or finished consumer products.